Cybin (TSE:CYBN) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cybin Inc., a leader in developing psychedelic-based therapeutics for mental health, will be featured in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference with CEO Doug Drysdale presenting in a fireside chat. The chat will be available on-demand starting June 27, 2024, and accessible through the company’s website. Cybin is advancing its mission to transform mental healthcare with proprietary compounds like CYB003 and CYB004, currently under development for major depressive and anxiety disorders.
For further insights into TSE:CYBN stock, check out TipRanks’ Stock Analysis page.